SCHEMBL30746604

SCHEMBL30746604

Cc1c(Cc2ccnc(N)c2F)cncc1Nc1ccc(F)cc1F

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 2/20 0.34
▸ LMNA P02545 1/20 0.33
▸ SHMT2 P34897 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ MAPK14 Q16539 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ MPO P05164 1/20 0.32
▸ FERMT2 Q96AC1 1/20 0.32
▸ CCNC P24863 1/20 0.32
▸ CDK8 P49336 1/20 0.32
▸ PIK3C3 Q8NEB9 2/20 0.32
▸ PIK3CA P42336 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ CACNA1B Q00975 1/20 0.31
▸ APBA1 Q02410 1/20 0.31
▸ CSF1R P07333 1/20 0.31
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26985336 1.00 DHFR (0.34) DHFRLMNASHMT2MAPK1MAPK14
SCHEMBL26984875 0.91 KDM4E (0.35) DHFRKDM4ECSF1R
SCHEMBL30746454 0.91 KDM4E (0.35) DHFRKDM4ECSF1R
SCHEMBL30746672 0.89 MAPK1 (0.35) DHFRMAPK1GAAL3MBTL1
SCHEMBL26984868 0.89 NUDT1 (0.42) DHFRMPOCSF1R
SCHEMBL26984845 0.89 MAPK1 (0.35) DHFRMAPK1GAAL3MBTL1
SCHEMBL30746443 0.89 MAP2K2 (0.35) —
SCHEMBL26985130 0.89 MAP2K2 (0.35) —
SCHEMBL30746622 0.88 — —
SCHEMBL30746594 0.88 KDM4E (0.31) DHFRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120129678-A Mitogen-activated protein kinase (MEK) inhibitors 耐斯泰德医疗公司 2025-06-10 — — CN disclosed
EP-4551558-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS Nested Therapeutics, Inc. (US) 2025-05-14 — — EP disclosed
WO-2024010925-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. (US) 2024-01-11 — — WO disclosed
Send feedback